Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Chaccour

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 28, 2020
Veterinary endectocides for malaria control and elimination: prospects and challengesCarlos Chaccour
The New England Journal of Medicine|April 15, 2026
Ivermectin to Control Malaria - A Cluster-Randomized Trial. ReplyCarlos Chaccour, Matthew Rudd
Lancet (London, England)|March 18, 2019
Advancing the repurposing of ivermectin for malariaCarlos Chaccour, N Regina Rabinovich
Malaria Journal|April 25, 2017
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathwayCarlos Chaccour, N Regina Rabinovich
Malaria Journal|April 25, 2017
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathwaysCarlos Chaccour, N Regina Rabinovich
Malaria Journal|January 13, 2016
Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector controlCarlos Chaccour, Gerry F Killeen
Medicina Clinica|July 5, 2020
Update on malariaRosauro Varo, Carlos Chaccour, Quique Bassat
Signal Transduction and Targeted Therapy|April 25, 2021
Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal DomainMarta Ribes, Carlos Chaccour, Gemma Moncunill
Malaria Journal|April 25, 2017
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyCarlos Chaccour, Felix Hammann, N Regina Rabinovich
Expert Review of Anti-Infective Therapy|February 17, 2015
Falsified antimalarials: a minireviewCarlos Chaccour, Harparkash Kaur, Jose Luis Del Pozo
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 28, 2020
Veterinary endectocides for malaria control and elimination: prospects and challengesCarlos Chaccour
The New England Journal of Medicine|April 15, 2026
Ivermectin to Control Malaria - A Cluster-Randomized Trial. ReplyCarlos Chaccour, Matthew Rudd
Lancet (London, England)|March 18, 2019
Advancing the repurposing of ivermectin for malariaCarlos Chaccour, N Regina Rabinovich
Malaria Journal|April 25, 2017
Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathwayCarlos Chaccour, N Regina Rabinovich
Malaria Journal|April 25, 2017
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathwaysCarlos Chaccour, N Regina Rabinovich
Malaria Journal|January 13, 2016
Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector controlCarlos Chaccour, Gerry F Killeen
Medicina Clinica|July 5, 2020
Update on malariaRosauro Varo, Carlos Chaccour, Quique Bassat
Signal Transduction and Targeted Therapy|April 25, 2021
Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal DomainMarta Ribes, Carlos Chaccour, Gemma Moncunill
Malaria Journal|April 25, 2017
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safetyCarlos Chaccour, Felix Hammann, N Regina Rabinovich
Expert Review of Anti-Infective Therapy|February 17, 2015
Falsified antimalarials: a minireviewCarlos Chaccour, Harparkash Kaur, Jose Luis Del Pozo
Pageof 8